Cancellation of state registration. Triesequence®

January 31, 2017
Trade names:
ICD-10:
XIII.M80-M85.M81.0    Postmenopausal osteoporosis
XIII.M80-M85.M81.1    Osteoporosis after removal of ovaries
XIV.N80-N98.N95.1    Menopause and menopause in women
XIV.N80-N98.N95.3    Conditions associated with artificially induced menopause
Trisequens, an antimycotic preparation, menopause, postmenopausal osteoporosis, menopause, menopausal disorders in the postmenopausal period

The Ministry of Health of the Russian Federation in accordance withArticle 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate No. N013450 / 01 dated Nov. 28, 2011 issued Novo Nordisk A / C, Denmark):

Trisequens® (trade name of the medicinal product)

- (international non-proprietary or grouping or chemical name)

tablets, film-coated (dosage form, dosage)

Novo Nordisk A / S, Denmark Novo Alle DK-2880, Bagsvaerd, Denmark (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by an authorized legal entity of Novo Nordisk LLC to cancel the state registration of a medicinal product.